Medicare Advantage premiums drop 16% for 2027 as insurers cut plans to boost margins

Key points

• CMS projects a 16% decline in weighted average MA premiums for 2027, reaching $12 per month.
• MA prescription drug premiums are expected to drop 38% year-over-year to an average of $7 after rebates.
• Stand-alone Part D premiums will increase slightly from $35.09 to $36 per month.
• The total number of MA plans will decrease slightly from 5,553 in 2026 to 5,532 in 2027.
• Insurers are cutting hundreds of thousands of individual plans, with Centene removing approximately 3,000 and Humana removing 2,400.
• CMS expects MA enrollment to reach 34 million, representing 47.4% of eligible beneficiaries, though it anticipates higher final numbers.

Background

This follows CMS’s earlier announcement in September 2026 regarding the 2027 rate increases and the end of the Part D Premium Stabilization Program. The current premium reductions come after a volatile 2026 enrollment period where nearly 3 million seniors had to find new coverage due to plan eliminations. The broader healthcare landscape in 2026 has seen rising costs, with large employers cutting benefits and the Social Security Administration projecting a 3.4% cost-of-living adjustment that may not fully offset inflation.

How outlets are covering it

Fierce Healthcare and USA Today emphasize the affordability gains, highlighting the 16% premium drop and CMS Administrator Mehmet Oz’s comments on maintaining accessible care. Healthcare Dive offers a more critical view, noting that the stable total plan count masks significant turmoil, with major insurers slashing individual plans and increasing out-of-pocket costs to resuscitate margins. While CMS projects enrollment stability, Healthcare Dive cites J.P. Morgan analysts who warn that the reduction in geographic footprints and plan options will likely disrupt enrollment for millions of beneficiaries. USA Today notes that while premiums drop, some plans may reduce drug formularies or increase cost-sharing to offset costs, a concern echoed by KFF experts.

Why it matters

The 2027 Medicare Advantage landscape presents a trade-off between lower premiums and reduced choice. While beneficiaries may see lower monthly costs, the aggressive cuts in plan availability and potential increases in cost-sharing could force many seniors to switch plans or face higher out-of-pocket expenses. This shift reflects insurers' strategic move to prioritize margin recovery over membership growth, potentially impacting the quality and breadth of coverage available to millions of older Americans during the upcoming open enrollment period.

What to watch

Insurers must notify enrollees of plan changes by September 30, 2026. Beneficiaries should review their current coverage before the open enrollment period begins on October 15, 2026, to ensure their plans remain available and meet their needs. CMS will monitor enrollment trends throughout the period, with final numbers expected to exceed current projections. The market will also watch for the impact of the ended Part D subsidy on prescription drug costs in 2027.